John Sellers

Partner
jsellers@cooley.com
Full contact info

I represent emerging companies and their investors at all stages, from new startup to world class public companies. I’m passionate about being part of disruptive new technologies.

About John

John Sellers focuses on representing emerging growth companies and the venture capital firms that invest in them. His practice includes company formations, venture capital financings, public offerings, mergers and acquisitions, strategic partnership and licensing transactions, and day-to-day corporate counseling.

View full bio

Experience

Harvey Announces $100 Million Series C

Harvey Announces $100 Million Series C

July 23, 2024

Cooley advised Harvey, a legal artificial intelligence platform, on its $100 million Series C financing, which brings Harvey to a $1.5 billion valuation.

Read more

Related contacts

Matthew Bartus
Partner, San Francisco
Rachel Proffitt
Partner and Chief Executive Officer, San Francisco
Caitlin Courtney
Partner, Palo Alto
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Los Angeles Santa Monica
Howard Morse
Partner, Washington, DC
John Paul Oleksiuk
Partner, New York
John Sellers
Partner, Palo Alto
Lei Shen
Partner, Chicago
David Silverman
Partner, New York
Sharon Connaughton
Special Counsel, Washington, DC
Kristin O'Hanlon
Special Counsel, San Francisco
Rebecca Ross
Special Counsel, Washington, DC
Tara Capsuto
Associate, San Francisco
Carl Min
Associate, San Francisco
Erica Russell
Associate, San Francisco
Tyler Saavedra-Buckley
Associate, San Francisco

Related Practices & Industries

Artificial Intelligence
Technology
Emerging Companies
Tax
CFIUS
Compensation and Benefits
Technology Transactions
Trademark, Copyright and Advertising
Cyber/Data/Privacy
Antitrust and Competition
Private Equity

NGM Biopharmaceuticals Announces $122 Million Series A

NGM Biopharmaceuticals Announces $122 Million Series A

July 17, 2024

Cooley advised NGM Biopharmaceuticals (NGM Bio), a wholly owned subsidiary of NGM Bio Holdings and a privately held biotechnology company focused on discovering and developing transformative therapeutics for patients, on its $122 million Series A financing.

Read more

Related contacts

Lauren Creel
Partner, Palo Alto
Chadwick Mills
Partner, San Francisco
Lindsy Solanki
Special Counsel, Palo Alto
Emily Iannarelli
Associate, Palo Alto
Alex Maki
Associate, Palo Alto
Jared S. Abes
Associate, Palo Alto
Eric Steiner
Paralegal Specialist, San Francisco
Brian Mitchell
Transactional Quantitative Analyst, New York
John Sellers
Partner, Palo Alto

Related Practices & Industries

Emerging Companies
Biotechnology
Healthcare
Life Sciences

Heartbeat Health Announces Series C Financing

Heartbeat Health Announces Series C Financing

July 9, 2024

Cooley advised Heartbeat Health, one of the top cardiovascular care companies in the US, on the close of its Series C financing led by Cressey & Company, a private investment firm focused on building leading healthcare services and information technology businesses.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
John Sellers
Partner, Palo Alto
Milson Yu
Partner, Palo Alto
Arielle H. Friehling
Associate, San Francisco
Seth Holoweiko
Associate, Colorado
Elaine Huang
Associate, Palo Alto
Kelley Harrington
Associate, Palo Alto
Brian Mitchell
Transactional Quantitative Analyst, New York

Related Practices & Industries

Healthcare
Life Sciences
Emerging Companies
Capital Markets

Clay Announces $46 Million Series B

Clay Announces $46 Million Series B

June 27, 2024

Cooley advised Clay, a company that helps go-to-market teams up-level their data enrichment and automate personalized outreach, on its $62 million Series B financing, valuing Clay at $500 million.

Read more

Related contacts

Brooke Nussbaum
Partner, Washington, DC
Emily Lee
Associate, Palo Alto
Josh Seidenfeld
Partner, Palo Alto
John Sellers
Partner, Palo Alto
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Joseph A. Kroon
Associate, Palo Alto

Related Practices & Industries

Emerging Companies
Tax
Technology

GrayMatter Robotics Announces $45 Million Series B

GrayMatter Robotics Announces $45 Million Series B

June 20, 2024

Cooley advised GrayMatter Robotics, an artificial intelligence-powered robotics leader empowering humans with intelligent automation, on its $45 million Series B financing.

Read more

Related contacts

Dave Young
Partner, Los Angeles Santa Monica
Sean O'Neill
Associate, Los Angeles Santa Monica
James H. Reizman
Associate, Los Angeles Santa Monica
Rebecca Ross
Special Counsel, Washington, DC
Kevin King
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
John Paul Oleksiuk
Partner, New York
John Sellers
Partner, Palo Alto

Related Practices & Industries

Emerging Companies
Artificial Intelligence
CFIUS
Trademark, Copyright and Advertising
View more

Admissions and credentials

California

Rankings and accolades

Northern California Super Lawyer: Business Law


M&A Transactions

involving sales of company clients to Google, Apple, IBM, Intel, Qualcomm, Boston Scientific, Stryker and Spectranetics